Consensus AstraZeneca PLC

Equities

AZN

GB0009895292

Real-time Estimate Cboe Europe 08:35:46 2024-02-23 am EST 5-day change 1st Jan Change
10,122 GBX +0.86% Intraday chart for AstraZeneca PLC +0.20% -4.58%

Evolution of the average Target Price on AstraZeneca PLC

Price target over the last 5 years

History of analyst recommendation changes

ef3b109b6a.aaKqnxXRyHA2SOjactHCWbWCuL2fil8Dnajm1by0oAQ.XtTi_iCymAYFDI-QJb2BPOXkiI7m6RZ0qMGPmPrz-F0O9e_2Y7CBKAc9jw~fceac42d00d9ae167a3f9148b66bf0d2
Berenberg: AstraZeneca Set for More Lung Cancer Success After Recent Pipeline Gains MT
ASTRAZENECA : Deutsche Bank reiterates its Sell rating ZD
Berenberg Trims AstraZeneca PT, Maintains Buy Rating MT
JPMorgan cuts Airtel Africa price target by 28% AN
ASTRAZENECA : Berenberg reiterates its Buy rating ZD
ASTRAZENECA : UBS keeps a Sell rating ZD
ASTRAZENECA : JP Morgan reiterates its Buy rating ZD
ASTRAZENECA : Jefferies reiterates its Neutral rating ZD
ASTRAZENECA : JP Morgan remains its Buy rating ZD
DZ Bank Lowers AstraZeneca's Fair Value, Keeps Hold Rating MT
Citi lifts GSK; Shore likes XPS Pensions AN
BMO Capital Cuts AstraZeneca's Price Target to $80 From $82, Outperform Rating Maintained MT
ASTRAZENECA : DZ Bank sticks Neutral ZD
Stifel Reduces AstraZeneca PT, Keeps Buy Rating MT
ASTRAZENECA : UBS lowers target price CF
AstraZeneca: further decline after two negative analyses CF
ASTRAZENECA : price target lowered by Barclays CF
ASTRAZENECA : Barclays reiterates its Buy rating ZD
Deutsche Bank starts Deliveroo at 'buy' AN
ASTRAZENECA : Deutsche Bank downgrades to 'sell CF
This time it's for real Our Logo
ASTRAZENECA : UBS reaffirms its Sell rating ZD
Deutsche Bank Downgrades AstraZeneca to Sell from Hold, Cuts PT MT
ANALYST RECOMMENDATIONS : Lululemon, Nvidia, PayPal, Spotify, Uber... Our Logo
ASTRAZENECA : Deutsche Bank gives a Sell rating ZD
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
126.8 USD
Average target price
161.8 USD
Spread / Average Target
+27.52%
High Price Target
215.4 USD
Spread / Highest target
+69.80%
Low Price Target
120 USD
Spread / Lowest Target
-5.38%

Consensus detail

Consensus revision (last 18 months)

Analysts covering AstraZeneca PLC

Berenberg Bank
DEUTSCHE BANK RESEARCH Emmanuel Papadakis
JPMORGAN James Gordon
UBS Matthew Weston
BERENBERG Luisa Hector
JEFFERIES Peter Welford
DZ Bank
BMO Capital
Stifel Nicolaus
BARCLAYS Emily Field
Deutsche Bank Securities
alphavalue Abhishek Raval
Jefferies & Co.
CREDIT SUISSE Dominic Lunn
HSBC
Argus
Morgan Stanley
GOLDMAN SACHS Keyur Parekh
Bank of America Securities/Merrill Lynch
Danske Bank Group
Kepler Capital Markets
Kepler Cheuvreux
DEUTSCHE BANK Emmanuel Papadakis
SVB Leerink
Bryan, Garnier & Co.
Societe Generale
Liberum Capital
ODDO BHF
BANK OF AMERICA (BOFA) Sachin Jain
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer